Helix BioPharma Market Cap

Helix BioPharma has a market cap or net worth of CAD 158.87 million as of March 9, 2026. Its market cap has increased by 295.21% in one year.

Market Cap

158.87M

Enterprise Value

158.72M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

1.85

Market Cap Chart

Since August 15, 1995, Helix BioPharma's market cap has increased from 9.38M to 158.87M, an increase of 1,593.06%. That is a compound annual growth rate of 9.69%.

Market Cap History

Date	Market Cap	% Change
Mar 6, 2026	158.87M	-12.24%
Dec 31, 2025	181.02M	314.90%
Dec 31, 2024	43.63M	-4.12%
Dec 29, 2023	45.50M	5.81%
Dec 30, 2022	43.00M	0.61%
Dec 31, 2021	42.74M	-36.74%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Satellos Bioscience	334.16M
ME Therapeutics Holdings	75.12M
Medicenna Therapeutics	68.40M
Sharp Therapeutics	67.67M
NervGen Pharma	434.88M
NurExone Biologic	56.27M
Sernova Biotherapeutics	54.63M
MedMira	45.33M

Market Cap Rankings